2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics

View by Date

Tuesday, June 7, 2022

6:50pm-7:00pm: Acute Cellular Rejection in Liver Transplant Recipients Following Vaccination Against Covid-19

R. Sarwar¹, O. Adeyi², N. Lim¹

Retransplantation and Other Complications • Hynes Room 313

6:50pm-7:00pm: Alloreactive Human Regulatory T Cell-Derived Extracellular Vesicles Exhibit Adenosinergic Mediated Suppression and Potential for Infectious Tolerance

B. Schreiber, S. Tripathi, A. Chandraker

Tregs and Tolerance • Hynes Room 304 / 306

6:50pm-7:00pm: Association of Psychosocial Clearance and Race in the Kidney Transplant Evaluation Process

V. S. Valbuena¹, C. Satarino², M. S. Anderson¹, J. Obayemi¹, T. J. Iwashyna³, R. Sung¹

Health Equity and Access II • Hynes Ballroom C

6:50pm-7:00pm: Augmented Reality in Hand-Assisted Retroperitoneal Donor Nephrectomy – Procedure Step Adjusted Evaluation for the Surgeons’ Benefits

R. Wahba¹, L. Krames², J. Hogervorst³, R. R. Datta¹, M. N. Thomas¹, P. Suppa³, D. L. Stippel¹

Machine Learning, Artificial Intelligence and Social Media in Transplantation • Hynes Room 210

6:50pm-7:00pm: Incidence and Outcomes of Fever of Unknown Origin After Kidney Transplant in the Modern Era

M. Jorgenson, S. Parajuli, B. Astor, C. Saddler, J. Smith, D. Mandelbrot

Kidney Transplant Infections • Hynes Ballroom B

6:50pm-7:00pm: Reduction in Opioid Discharge Prescribing for Kidney Transplant Recipients Through Implementation of a Standardized Opioid Prescribing Policy

S. Fredrick¹, K. Dokus², J. Cooley¹, A. Dulen³, J. Melaragno¹

Quality Assurance Process Improvement & Regulatory Issues • Hynes Room 206

6:50pm-7:00pm: Rejection After Liver Transplantation: What Can We Learn from Transcriptomic Analysis?

H. J. Braun¹, D. Amara², A. Zarinsefat¹, G. Szabo¹, Z. Laszik¹, P. Stock¹, N. Ascher¹

Chronic Organ Rejection • Hynes Room 309

6:50pm-7:00pm: Safety and Efficacy at 4 Years in Post-Liver Transplant Patients with Chronic Kidney Disease Receiving Tenofovir Alafenamide (TAF) for HBV Prophylaxis

E. Gane¹, B. George¹, D. Ray-Chaudhuri¹, T. Mules¹, C. D. Holt², H. Wang², V. Suri², A. Gaggar², A. Osinusi², J. Flaherty²

Viral Hepatitis • Hynes Room 312

6:50pm-7:00pm: Single Center Experience of Utilizing Genetic Testing (Renasight) in the Kidney Transplant Setting

Y. A. Qazi, W. Mon, M. Renzu, C. Choi, A. Qazi, M. Smogorzewski

Recurrent Kidney Disease & Genetics • Hynes Room 310

6:50pm-7:00pm: Tacrolimus and Mycophenolic Acid Therapeutic Exposure Targets in Black and White Kidney Transplant Recipients

K. Tornatore¹, K. Attwood¹, S. Chang¹, A. Gundroo², B. Murray¹

Non-Organ Specific: Pharmacokinetics / Pharmacogenomics / Drug interactions • Hynes Room 311